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Abstract—Current analysis of tumor proliferation, the most
salient prognostic biomarker for invasive breast cancer, is lim-
ited to subjective mitosis counting by pathologists in localized
regions of tissue images. This study presents the first data-
driven integrative approach to characterize the severity of tu-
mor growth and spread on a categorical and molecular level,
utilizing multiple biologically salient deep learning classifiers
to develop a comprehensive prognostic model. Our approach
achieves pathologist-level performance on three-class categorical
tumor severity prediction. It additionally pioneers prediction
of molecular expression data from a tissue image, obtaining
a Spearman’s rank correlation coefficient of 0.60 with ex vivo
mean calculated RNA expression. Furthermore, our framework is
applied to identify over two hundred unprecedented biomarkers
critical to the accurate assessment of tumor proliferation, vali-
dating our proposed integrative pipeline as the first to holistically
and objectively analyze histopathological images.
I. INTRODUCTION
Breast cancer is the most common cancer in women world-
wide, with over 1.2 million new cases diagnosed in 2012 [1].
Cancer assessment is influenced by environmental and clinical
factors, but it is universally accepted that tumor proliferation
speed (tumor growth) is an important biomarker representative
of progression rate and outcomes [2], [3]. Specifically, high
proliferation speed is associated with worse outcomes [2].
The assessment of this biomarker critically influences patient
treatment plans, allowing for patients with more aggressive
tumors to be treated with the corresponding therapy [3].
In a clinical setting, tumor proliferation is manually assessed
by pathologists under a regime of counting mitotic figures in
hematoxylin & eosin (H&E) stained histological slide prepa-
rations that are examined under a high powered microscope.
Although ubiquitous, the process of counting mitoses has
been reported to suffer from reproducibility problems that
reflect the underlying subjectivity of the process [2]. In addi-
tion, the simple methodology of pathologist mitosis counting
and subsequent thresholding fails to account for pathological
features including tumor extent, tissue density, and relative
mitosis density. The mean expression of eleven prognostic
RNA sequences, an objective measure of the proliferation
score, requires extensive ex vivo molecular tests, relegating
current practices to an inadequate and subjective pathologist
diagnosis [3], [4].
This study introduces a comprehensive deep learning-based
pipeline constructing and unifying models across several asso-
ciated tasks of tumor localization, mitotic figure identification,
and high-level feature extraction to classify categorical tumor
grades (0–2) and predict RNA proliferation speed scores from
histological whole slide images (WSIs). Furthermore, we aim
to identify salient biomarkers related to tumor diagnosis to
serve as the basis for future studies. The data-driven integrative
approach presented here is generalizable and will be useful to
analyze other cancerous tumors.
II. METHODS
A. Dataset Description
Three datasets were used in this study to train primary
and auxiliary models [5]. Our primary evaluation dataset
consisted of 500 whole slide images with magnification levels
from 10× to 40× that are annotated with a tumor score
based on mitosis counting by pathologists and a molecular
(RNA) proliferation score [5]. We additionally use 73 2 mm2
magnified images annotated with mitotic figures and 148 WSIs
partially annotated with tumor (high cellularity) regions for
supplemental training.
B. Data Mining, WSI Normalization, and Tissue Extraction
As our WSIs originate from three international pathology
centers, each exhibited different staining methods. To ensure
that such variations in the color and intensity of H&E staining
would not hamper the effectiveness of subsequent quantitative
image analysis, we employed the Bejnordi et al’s WSI Color
Standardization (WSICS) procedure [6]. Normalizing each
WSI and images from auxiliary datasets ensured that our
subsequent methods exhibited stain invariance between tissue
preparation methods. Tissue regions were next extracted from
each stain standardized input WSI using Otsu’s method on a
HSV representation of the original RGB image [7], [8]. We
subsequently removed small artifacts and expanded remaining
regions via binary dilation to obtain a holistic tissue mask.
C. Network Construction
Our pipeline (Fig. 1) next performed three tasks: metastatic
tumor localization, mitotic figure identification, and WSI
general feature extraction. We used a magnification level of
10× for the tumor localization process to identify high-level
patterns, and we conducted mitosis identification and feature
extraction on the 40× level for detailed analysis.
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Fig. 1: Analysis Process for Tumor Proliferation. Each multiresolution input WSI is sequentially processed with a series of
biologically salient steps including tissue extraction, tumor localization, and mitotic figure tumor-specific feature extraction.
These processes are combined with general extracted features to generate molecular and categorical predictions.
1) Metastatic Tumor Localization: Having extracted and
normalized tissue regions from each input WSI, it is important
to identify candidate regions for mitotic activity indicative of
tumor proliferation. Such regions are biologically character-
ized as high-cellularity areas with proliferative activity often
represented at the edges of the tissue abnormality.
Fig. 2 depicts the four employed network architectures,
the first three of which are recognized as state-of-the-art
convolutional neural networks (CNNs) for object recogni-
tion [9]–[11]. Each CNN generated output tumor probability
heatmaps with a “sliding-window” approach [13], classifying
overlapping tissue patches for tumor probability and assigning
the resulting value to the center pixel of each patch. The fourth
network, which we named LocNet, reduced the number of free
parameters and operated on a fully convolutional paradigm
[14]. LocNet allowed for arbitrarily sized inputs (we use
1k × 1k patches) and produced downsampled corresponding
heatmaps for each patch as opposed to singular probability
outputs. We resized and stitched these probability heatmaps
over each WSI to rapidly generate a comprehensive heatmap.
Network training was framed as an active learning problem
[15] as each annotated image contained a non-exhaustive list of
tumor regions. We, therefore, separated the process into two
components, with the first stage defining annotated patches
as positive and identifying a random sample of remaining
tissue patches as negative. Heatmaps were subsequently pro-
duced using each model and additional regions predicted as
positive with over 95% confidence were appended to the
initial positive training set. All models were retrained with the
refined data; subsequent second stage results better eliminated
regions misclassified in the first stage. The trained models were
used both to identify tumor regions within which to perform
mitotic figure identification and to provide informative features
regarding tumor shape, density, area, extent, and location.
2) Mitotic Figure Identification: We next constructed mi-
totic figure detectors to identify biologically salient features
within tumor areas. Due to aberrant tumor chromosomal
makeup, mitotic figure appearances may vary from typical
examples of hyperchromatic objects with an absence of a clear
nuclear membrane and hairy protrusions around edges.
Current state-of-the-art methods in the field of computa-
tional mitosis identification are trained and evaluated on high
quality, standardized, and localized tumor regions with well-
defined mitotic figures [16]–[18]. However, such methods fail
to generalize to our WSI dataset as they often simply learn
standardized color and texture filters from their homogeneous
training dataset. Prior methods are additionally unable to
rapidly generate mitosis identification results over an entire
whole slide image. Here, we introduce and apply robust color,
texture, and scale invariant mitosis detection networks that
rapidly identify mitoses on individual patches and WSIs.
The five networks employed are depicted in the middle
section of Fig. 2. DenseNet, requiring the most parameters,
constructed repeated connections between network layers to
develop a robust approach. Although the GoogLeNet architec-
ture and its modified fully convolutional counterpart performed
reasonably well, the additional complexity encoded within the
network architecture excessively distilled the already small
mitotic figures. To remedy this issue, we applied the LocNet
model and developed a specialized architecture called Mi-
tosNet. LocNet and MitosNet exhibited fewer (yet more fine-
tuned) layers, capturing the variance between mitoses without
degrading effective inference.
To reduce the false positive rate for identified mitoses, we
followed a two-stage training procedure similar to Section
II-C1 using a dataset of pathologist annotated mitotic figures.
We initially identified the locations and areas of all nuclei
using morphological methods. We defined positive training
patches as those nuclei annotated as mitotic, and we identified
Network # Layers # Params RF Input Output Propagation Time
Metastatic Tumor Localization (II-C1)
GoogLeNet [9] 27 5.97 M 49 224× 224 1 × 2 562.62 ms
ResNet-34 [10] 34 13.9 M 49 256× 256 1 × 2 204.55 ms
VGG-13 [11] 39 134.3 M 9 224× 224 1 × 2 208.85 ms
LocNet∗ 12 4.55 M 9 1k × 1k 63× 63 77.47 ms
Mitotic Figure Identification (II-C2)
DenseNet [12] 118 1.02 B 9 224× 224 1 × 2 500.09 ms
GoogLeNet [9] 27 5.97 M 49 224× 224 1 × 2 562.62 ms
GoogLeNet FCN∗ 27 5.97 M 49 1k × 1k 48× 48 340.53 ms
LocNet∗ 12 4.55 M 9 1k × 1k 63× 63 77.47 ms
MitosNet∗ 6 21.1 K 16 1k × 1k 63× 63 44.21 ms
General Feature Extraction (II-C3)
Tumor + 3C/P∗ 18 5.16 M 64 1k × 1k 1× 3 492.4 ms
Mitosis + 3C/P∗ 12 5.93 M 64 1k × 1k 1× 3 143.1 ms
Fig. 2: Network Architectures. Parameters and statistics characterizing the seminal networks developed in Section 2. The prop-
agation time column characterizes the mean forward pass time for one input image, and the RF column represents the receptive
field (in pixels) of each network. ∗New networks specifically developed for this work; C/P indicates Convolution/Pooling layers.
a random sample of other nuclei as negative. After the first
stage of training and output heatmap generation, we subjected
our mitosis identifications to further pathologist evaluation
and subsequently retrained our models accounting for initially
misidentified instances. The resulting robust trained models
were used to characterize mitoses in terms of spatial distri-
bution and shape-specific attributes; the process of extracting
these features is detailed in Section II-D.
3) WSI General Feature Extraction: In addition to develop-
ing methods for the identification of anatomical structures in
tumor severity analysis, we created end-to-end networks that
predict the output categorical severity grade of the whole slide
image from individual patches. These developed networks are
defined in the last section of Fig. 2; each model utilizes
outputs of tumor and mitosis networks to extract detailed
computational features. Patches are extracted from original
WSIs and input to the first network (with static weights)
which computes coarse features corresponding to either mi-
tosis identification or tumor localization. Convolutions from
the first network’s feature volume are next mapped to the
input of a second network (with dynamic weights). The second
network performed categorical predictions and extracted WSI
features. These 1,024 features, combined with 3 predicted class
probabilities, were incorporated in the final predictive model.
D. Tumor-Specific Feature Extraction
We applied our mitosis detection and tumor localization
methods to identify biologically salient features in WSIs on
both a patch-based and a whole slide level. Each approach
allowed for extraction of features with varying granularities.
Specifically, we preferentially selected fifty patches from
the fringes of localized tumor regions with the largest area.
Each patch, a 1k×1k tissue sample at magnification level 40×,
was input to our mitosis detectors which produced heatmaps
of corresponding size identifying mitotic figure probability in
the input image. We additionally represented each WSI with a
comprehensive heatmap depicting mitotic figures in all tumor
regions. Both individual patches and the WSI heatmap are
used to compute biological and data-driven mitosis features.
Biological Features. From each selected patch, we ex-
tracted fifty morphometric and intensity based features to
characterize biologically salient structural mitosis components.
These features describe compositional and formational pat-
terns that pathologists might observe. In addition, we charac-
terized the distribution of mitoses throughout the entire WSI
with sixty architectural features. Particularly, we analyzed the
sparsity of mitosis distribution and second-order attributes
including kurtosis, entropy, and skewness, providing a high-
level interpretation of proliferative activity.
Data-Driven Features. Within each magnified patch, we
additionally computed abstract deep learning-based features
that represent attributes from learned filters. We segmented
a 63 × 63 tissue patch around each identified mitosis for
input to our mitosis detection networks. Each mitotic figure
was subsequently characterized by 4,096 attributes to describe
mitosis-specific structural minutiae. As each patch consisted of
Ni mitotic figures and was thereby associated with 4096×Ni
distinct computational attributes, feature standardization was
performed. We conducted post-processing k-means clustering
on all individual mitosis feature vectors (of length 4,096) from
every WSI patch in a 200-dimensional vector space. Each
vector was associated with a cluster label ∈ [1, 200] identifying
its most similar sub-space. Finally, each WSI was distilled
into a 200-bin histogram with frequencies corresponding to the
cluster labels of each mitotic region within extracted patches,
resulting in a fixed data-driven feature vector of length 200.
All characteristic features extracted from tumor localization
results (II-C1), general extraction methods (II-C3), and both
deep learning and biological tumor-specific mitotic attributes
Fig. 3: Receiver Operating Characteristic Curves. A depiction
of the one vs all predicted class based ROC curves with
respective AUC values.
(II-D) were used to predict the severity of tumor proliferation.
III. EXPERIMENTS AND RESULTS
A. Performance Evaluation
Categorical Tumor Severity. A receiver operating char-
acteristic (ROC) curve [19] detailing the ratio of true pos-
itives and false positives at varying thresholds is depicted
in Fig. 3. Each class was predicted in a one vs all manner
with mean values determined in five-fold cross-validation.
The resulting micro-average AUROC of 0.78 validates our
overall f -measure of 0.62, establishing the model’s powerful
discriminative potential among the three classes. Our method
additionally achieved an accuracy of 0.72 (95% CI: 0.67,
0.76) when compared to pathologist severity gradation, indi-
cating marginal deviation of our predictions from the inter-
pathologist agreement of 0.79 (95% CI: 0.70, 0.85) [2].
Molecular RNA Expression. Our best-performing regres-
sion model achieved a mean squared error of 0.119. Fig. 4
depicts the correlation between our regression predictions and
the calculated mean expression of eleven prognostic RNA
strands. Our model, the first ever to predict gene expression
data from histopathological image slides, achieves a Pearson’s
correlation coefficient value r = 0.58 and a Spearman’s rank
coefficient ρ = 0.60 (p < 0.001). Along with the low MSE,
these results indicate the ability of our pipeline not only to
match categorical pathologist diagnosis but also to provide
significantly more salient information regarding the biologi-
cal underpinnings defining the severity of tumor tissue. The
overall performance metrics indicate the prognostic potential
of our model in effectively evaluating histopathological slides
without a molecular examination.
B. Specific Biomarker Analysis
Our study further elucidated important biomarkers (regres-
sion features with p < 0.005) most important for proliferation
Fig. 4: Molecular Expression Prediction Results. A depiction
of the correlation between pipeline RNA expression prediction
(x-axis) and calculated RNA expression from a full biopsy.
evaluation. The number of mitoses, currently the sole feature
used to manually diagnose tumor proliferation, was confirmed
as relevant. Additionally, the standard deviation of the nucleus
area of all identified mitoses was implicated. This attribute,
known to characterize malignant neoplasms and dysplasia, was
recently associated with breast cancer diagnosis [20].
In addition, the p-values and predictive significance of
several new biomarkers suggest that they are significantly
related to the progression of breast cancer. The mean mitotic
eccentricity over each WSI, a feature characteristic of the
development of a cleavage furrow in mitotic figures [21], was
found to be relevant, suggesting the differential importance of
cytokinetic figures in diagnosis. The importance of composi-
tional features of tumor tissue structures suggested prognostic
information embedded in specific forms of tissue structure
across the entire WSI. In addition to these interpretable
biological features, low-level configurational and formational
patterns identified by MitosNet were deemed relevant, denot-
ing differential mitotic stages as prognostically significant.
IV. CONCLUSION
This study presented the first completely data-driven ap-
proach to develop and integrate numerous biologically salient
classifiers into a single invasive breast cancer prognostic
model. This model was used to predict tumor growth on a
categorical and molecular scale and to discover novel image-
related biomarkers critical to disease diagnosis. With our
prediction framework performing equivalent to pathologist
grading and capturing the underlying complexity presented
within tissue structure, early and less costly diagnoses for
invasive breast cancer may allow for more effective and
targeted treatments in clinical practice.
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